In the week from December 20 to December 24, 2021, in terms of main board IPO, two enterprises landed on the main board of Shanghai stock market and one enterprise landed on the main board of Shenzhen stock market; One enterprise has obtained the issuance approval; 1 enterprise held the meeting; IPO applications of 3 enterprises were newly accepted.
Next week, on December 30, an IPO will be held for Jinhui mining, which is to be listed on the Shanghai main board.
Specifically, Yongan futures and Inner Mongolia Xinhua landed on the Shanghai main board; The Yangtze River Materials landed on the Shenzhen main board; The company that passed the meeting is Baihe Co., Ltd., which plans to be listed on the Shanghai main board; Hefu China got the IPO approval this week and planned to land on the main board of Shanghai stock market.
in terms of IPO , when Zhou Yongan Futures (600927. SH) and Inner Mongolia Xinhua (603230. SH) landed on the Shanghai main board on December 23 and 24 respectively, they rose 44.02% and 44.04% on the first day of listing; Changjiang materials (001296. SZ) landed on the Shenzhen main board on December 24, up 44.01% on the first day of listing. As of the closing on December 24, Yong’an futures closed at 28.47 yuan / share, up 10.01% on the same day.
in terms of audit by the development and Audit Commission , during the above period, one enterprise passed the meeting, Weihai Lily Biotechnology Co., Ltd. (hereinafter referred to as “lily shares”), which is planned to be listed on the Shanghai main board.
This is the second IPO of Lily shares and the second meeting of this round of declaration.
Lily Co., Ltd., founded in 2005, is mainly engaged in the R & D, production and sales of nutritional and health food. It has three brands of “lily Kang”, “Fuzi” and “hongyangshen”.
In May 2015, Baihe biology opened its first IPO, with the target sector of gem and the counseling institution of Gf Securities Co.Ltd(000776) . However, in October 2019, due to the withdrawal of materials, the IPO review of Lily biology was terminated.
In February 2020, Baihe Co., Ltd. made another sprint for IPO without replacing the counseling institution and planned to log on the main board of Shanghai Stock Exchange. On November 18 this year, Lily shares held a meeting, but the voting was suspended; On December 23, the meeting was held again, and the result was adopted.
At this meeting, the development and examination committee was concerned that the income of Baihe shares mainly came from contract business, and the income of independent brands was less; Independent brand sales are mainly realized through distribution mode; During the reporting period, the company’s comprehensive gross profit margin and main business gross profit margin increased period by period. The company is required to explain this. At the same time, the IEC also inquired whether the company has major violations of laws and regulations and whether it constitutes a substantive obstacle to the issuance.
IPO approval . On December 24, the CSRC approved and issued an IPO approval for Hefu China.
Statistics show that Hefu (China) Medical Technology Co., Ltd. (hereinafter referred to as “Hefu China”) was established in 2000 and is a channel in the field of medical circulation.
This is the second time that Hefu China has applied for A-share listing. The company’s IPO is sponsored by Haitong Securities Company Limited(600837) . It plans to issue 99.5132 million shares and raise 667 million yuan. It plans to invest in the intensive marketing of medical testing and the introduction of high-tech instruments, information upgrading and medical management exchange center projects, as well as supplement working capital.
In July 2019, Hefu China applied for IPO for the first time. The sponsor is Huatai Securities Co.Ltd(601688) , and it is planned to be listed on the Shanghai Stock Exchange. In August 2020, Hefu medical and Huatai jointly signed a listing counseling termination agreement, which was terminated due to “the adjustment of the company’s overall development strategy”. After that, Hefu China signed a listing guidance agreement with Haitong Securities Company Limited(600837) to be listed on the gem. Since then, the proposed listing plate has been changed to the main board of Shanghai Stock Exchange.
in terms of enterprises at the meeting next week, the official website of the CSRC shows that the 18th development and Examination Committee of the CSRC is scheduled to hold the 143rd work meeting of the development and examination committee in 2021 on December 30, 2021, and the issuer reviewed is Jinhui Mining Co., Ltd. (initial).
in terms of new acceptance , according to the official website of the CSRC, as of December 23, three new acceptance enterprises had been added in Shanghai stock market.
Among them, the IPO team of Jiangxi salt industry group is “Shengang securities + zhongshenhua + Beijing Jiayuan”; Zhongzhong Technology (Tianjin), the IPO team is ” Guotai Junan Securities Co.Ltd(601211) + Lixin + Guohao (Beijing)”; Bohai Securities, the IPO team is ” Everbright Securities Company Limited(601788) + PwC Zhongtian + Beijing Jinchengtongda”.
(First Finance)
